Neurochemical neutralization of methamphetamine with high‐affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Synapse

• Publication date

  2000-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/(SICI)1098-2396(20000301)35:3<222::AID-SYN7>3.0.CO;2-KPMID 10657029
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Doses of GBR12909 that suppress cocaine self‐administration in non‐human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans

  1999cited by this paper
• In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor.

  1997cited by this paper
• The Neurobiology of Addiction

  1997cited by this paper
• Neurobiology of addiction.

  1996cited by this paper
• Sustained decrease in cocaine-maintained responding in rhesus monkeys with 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-hydroxy-3-phenylpropyl) piperazinyl decanoate, a long-acting ester derivative of GBR 12909.

  1996cited by this paper
• Increasing morbidity and mortality associated with abuse of methamphetamine--United States, 1991-1994.

  1995cited by this paper
• GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat.

  1994cited by this paper
• From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters.

  1993cited by this paper
• Identification of a GBR12935 homolog, LR1111, which is over 4,000‐fold selective for the dopamine transporter, relative to serotonin and norepinephrine transporters

  1993influential reference
• Amphetamine: effects on catecholamine systems and behavior.

  1993cited by this paper
• Neurotoxic Amphetamine Analogues: Effects in Monkeys and Implications for Humans a

  1992cited by this paper
• Neurochemical Profile of Lu 19‐005, a Potent Inhibitor of Uptake of Dopamine, Noradrenaline, and Serotonin

  1985cited by this paper

• Cobalt-catalyzed Enantioselective Hydrogenation of Trisubstituted Carbocyclic Olefins: An Access to Chiral Cyclic Amides.

  2023cites this paper
• A neuroimaging study of altered cortical and subcortical volume in adolescent methamphetamine users

  2023cites this paper
• Bacopa Protects against Neurotoxicity Induced by MPP+ and Methamphetamine

  2022cites this paper
• Alterations of Mitochondrial Structure in Methamphetamine Toxicity

  2022cites this paper
• RUNNING HEAD: DOPAMINE AND DISCOUNTING META-ANALYSIS 1 Title: Dopaminergic modulation of reward discounting: a systematic review and meta-analysis Authors:

  2020cites this paper
• Metal free decarboxylative aminoxylation of carboxylic acids using a biphasic solvent system.

  2020cites this paper
• A Sympathetic Treatment for Obesity.

  2020cites this paper
• Pharmacological characterization of the aminorex analogs 4-MAR, 4,4'-DMAR, and 3,4-DMAR.

  2019cites this paper
• A high‐quality homology model for the human dopamine transporter validated for drug design purposes

  2019cites this paper
• The Effects of 5-HT2C Receptor Inverse Agonist, Agonist, and Antagonist on Methamphetamine-Induced Behavioral Sensitization and Reinstatement of Drug-Seeking Behavior in Mice

  2018cites this paper
• Using Ca2+-channel biosensors to profile amphetamines and cathinones at monoamine transporters: electro-engineering cells to detect potential new psychoactive substances

  2018cites this paper
• Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release

  2017cites this paper
• Dopaminergic modulation of reward discounting in healthy rats: a systematic review and meta-analysis

  2017cites this paper
• Antidepressant indatraline induces autophagy and inhibits restenosis via suppression of mTOR/S6 kinase signaling pathway

  2016cites this paper
• Mitochondria: key players in the neurotoxic effects of amphetamines

  2015cites this paper
• Diminished serum repetin levels in patients with schizophrenia and bipolar disorder

  2015cites this paper
• Toward live-cell imaging of dopamine neurotransmission with fluorescent neurotransmitter analogues.

  2015cites this paper
• The neurotoxicity of amphetamines during the adolescent period

  2015cites this paper
• Monoamine Reuptake Inhibitors in Parkinson's Disease

  2015cites this paper
• Dopamine Receptors and the Persistent Neurovascular Dysregulation Induced by Methamphetamine Self-Administration in Rats

  2014cites this paper
• Investigation of the nitronate Nazarov cyclization

  2014cites this paper
• Brain and Peripheral Organ Toxicity of "Ecstasy" in Adolescent Rats in Human Relevant Doses

  2014cites this paper
• 3-Aryl-3-arylmethoxyazetidines. A new class of high affinity ligands for monoamine transporters.

  2013cites this paper
• Substituted methcathinones differ in transporter and receptor interactions.

  2013cites this paper
• Synthesis of Novel Azetidines

  2013cites this paper
• Investigating the effects of an acute dose of benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) alone and in combination on the human brain using functional Magnetic Resonance Imaging (fMRI)

  2012cites this paper
• Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study

  2012cites this paper
• Striatal Volume Increases in Active Methamphetamine-Dependent Individuals and Correlation with Cognitive Performance

  2012influential citation
• Functional and Structural Brain Changes Associated with Methamphetamine Abuse

  2012cites this paper
• In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery

  2011cites this paper
• Molecular-biological problems of drug design and mechanism of drug action

  2011cites this paper
• Classical and emerging mechanisms

  2010cites this paper
• Substrate and drug binding sites in LeuT.

  2010cites this paper
• Evidence for noncompetitive modulation of substrate‐induced serotonin release

  2010cites this paper
• Amphetamine toxicities

  2010cites this paper
• Amphetamine Derivatives as Appetite Suppressants

  2009cites this paper
• Serotonergic drugs and valvular heart disease

  2009cites this paper
• Effects of a novel dopamine uptake inhibitor upon extracellular dopamine from superfused murine striatal tissue.

  2009cites this paper
• Antidepressant specificity of serotonin transporter suggested by three LeuT–SSRI structures

  2009cites this paper
• Treatment Options in Methamphetamine Addiction and Withdrawal

  2009cites this paper
• Comparative study of the influence of Thy1 deficiency and dietary iron deficiency on dopaminergic profiles in the mouse striatum

  2008cites this paper
• Predicting Positive and Negative Treatment Responses to Stimulants with Brain SPECT Imaging

  2008cites this paper
• 5-HT3 Receptor Ligands and Their Effect on Psychomotor Stimulants

  2008cites this paper
• Nociceptin attenuates methamphetamine abstinence-induced withdrawal-like behavior in planarians.

  2008cites this paper
• Neurochemical and Neurobehavioral Consequences of Methamphetamine Abuse

  2007cites this paper
• α1-Adrenergic Receptors Mediate the Locomotor Response to Systemic Administration of (±)-3,4-Methylenedioxymethamphetamine (MDMA) in rats

  2007cites this paper
• Neurobiology of 3,4-Methylenedioxymethamphetamine (MDMA, or ""Ecstasy"")

  2007cites this paper
• Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices.

  2007cites this paper
• Blockade of noradrenaline transport abolishes 4-methylthioamphetamine-induced contraction of the rat aorta in vitro.

  2006cites this paper
• Dopamine transporter ligands: recent developments and therapeutic potential.

  2006cites this paper
• Effects of N-nitrosofenfluramine, a component of Chinese dietary supplement for weight loss, on CD-1 mice

  2006cites this paper
• Therapeutic potential of monoamine transporter substrates.

  2006cites this paper
• Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.

  2006cites this paper
• Methamphetamine-induced disruption of dopamine homeostasis : the ins and outs of transport

  2006cites this paper
• Guidelines for the medical management of patients with methamphetamine-induced psychosis

  2006cites this paper
• Targeted screening for biogenic amine transporters: potential applications for natural products.

  2005cites this paper
• Acute and chronic continuous methamphetamine have different long-term behavioral and neurochemical consequences.

  2005cites this paper
• A 5-HT(2C) receptor-mediated interaction between 2,5-dimethoxy-4-methylamphetamine and citalopram in the rat.

  2004cites this paper
• Effects of Methamphetamine and Lobeline on Vesicular Monoamine and Dopamine Transporter-Mediated Dopamine Release in a Cotransfected Model System

  2004cites this paper
• Synthesis and pharmacological evaluation of 3-(3,4-dichlorophenyl)-1-indanamine derivatives as nonselective ligands for biogenic amine transporters.

  2004cites this paper
• Monoamine transporters and psychostimulant drugs.

  2003cites this paper
• Suppressive effects of trihexyphenidyl on methamphetamine‐induced dopamine release as measured by in vivo microdialysis

  2003cites this paper
• In vitro neuronal and vascular responses to 5-hydroxytryptamine: modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine.

  2002cites this paper
• [MDMA (ecstasy): neuroendocrine and behavioral features].

  2002cites this paper
• Preclinical Evaluation of GBR12909 Decanoate as a Long‐Acting Medication for Methamphetamine Dependence

  2002cites this paper
• Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice

  2002cites this paper
• Appetite Suppressants as Agonist Substitution Therapies for Stimulant Dependence

  2002cites this paper
• Serotonin releasing agents. Neurochemical, therapeutic and adverse effects.

  2002cites this paper
• Baclofen decreases methamphetamine self-administration in rats

  2002cites this paper
• Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain.

  2002cites this paper
• Studies of the biogenic amine transporters. VIII: Identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding

  2002cites this paper
• Striatal dopamine output is compromised within +/− BDNF mice

  2002cites this paper
• Therapeutic and adverse actions of serotonin transporter substrates.

  2002cites this paper
• Experimentally induced aggressive behavior in subjects with 3,4-methylenedioxy-methamphetamine ("Ecstasy") use history: psychobiological correlates.

  2001cites this paper
• Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment.

  2001cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• Synthesis and biological evaluation of tropane-like 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909) analogues.

  2001cites this paper
• Differential interaction of GBR 12909, a dopamine uptake inhibitor, with cocaine and methamphetamine in rats discriminating cocaine

  2001cites this paper
• Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

  2001cites this paper
• Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system.

  2001cites this paper
• Uptake and release effects of diethylpropion and its metabolites with biogenic amine transporters.

  2000cites this paper
• Neurochemical neutralization of amphetamine-type stimulants in rat brain by the indatraline analog (-)-HY038.

  2000cites this paper
• Design, synthesis, and monoamine transporter binding site affinities of methoxy derivatives of indatraline.

  2000cites this paper
• Reinforcing and discriminative stimulus effects of RTI 111, a 3-phenyltropane analog, in rhesus monkeys: interaction with methamphetamine

  2000influential citation
• Methamphetamine Dependence: Medication Development Efforts Based on the Dual Deficit Model of Stimulant Addiction

  2000cites this paper
• Neurochemical mechanisms of phentermine and fenfluramine: Therapeutic and adverse effects

  2000cites this paper